Fortress Biotech Stock Price - FBIO

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Fortress Biotech Inc FBIO NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0599 -2.27% 2.5801 2.69 2.57 2.66 2.64 11:41:37
Bid Price Ask Price Spread Spread % News
2.56 2.58 0.02 0.78% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
672 154,491 $ 2.63 $ 406,306 488,945 1.03 - 2.94
Last Trade Time Type Quantity Stock Price Currency
11:41:24 100 $ 2.5801 USD

Fortress Biotech Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 182.62M 70.78M $ -84.15M -1.94 - 48.86M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Fortress Biotech News

Loading Messages....

Latest FBIO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FBIO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.792.942.492.68678,356-0.2099-7.52%
1 Month2.492.942.022.61564,8180.09013.62%
3 Months1.412.941.272.30376,0861.1782.99%
6 Months1.272.941.201.95326,0061.31103.16%
1 Year1.062.941.031.85481,8161.52143.41%
3 Years2.265.540.492.32292,2300.320114.16%
5 Years2.355.540.492.72279,7560.23019.79%

Fortress Biotech Description

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Your Recent History
Fortress B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.